Stensen duct dilation: Case series of minimally invasive treatment

Abstract : Stensen's duct dilation is a rare condition characterized by a global or partial idiopathic dilation of the Stensen duct. Affected individuals usually show either aesthetically compromised features, such as a tubular-shaped swelling in the cheek, or with mildly painful inflammatory episodes. Three women between ages 61 and 67years were diagnosed with Stensen duct dilation after sialo-magnetic resonance imaging (MRI). They were treated with botulinum toxin A (BTX-A). Our preliminary results suggest that BTX-A was efficient as a suspensive treatment. BTX-A should remain a first-line treatment of the early silent symptoms of Stensenduct dilation, such as swelling and aesthetic issues. The use of BTX-A avoids more serious procedures and further complications. Copyright © 2019 Elsevier Inc. All rights reserved.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02102540
Contributor : Estelle Bogdanski <>
Submitted on : Wednesday, April 17, 2019 - 2:24:53 PM
Last modification on : Friday, April 19, 2019 - 1:40:12 AM

Identifiers

Collections

Citation

Marc-Kevin Le Roux, Nicolas Graillon, Mehdi Hadj-Saïd, Ugo Scemama, Jean-Christophe Lutz, et al.. Stensen duct dilation: Case series of minimally invasive treatment. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, New York, NY : Elsevier, 2019, ⟨10.1016/j.oooo.2019.01.078⟩. ⟨hal-02102540⟩

Share

Metrics

Record views

3